Literature DB >> 26617744

Muc-1 promotes migration and invasion of oral squamous cell carcinoma cells via PI3K-Akt signaling.

Ping Li1, Li Ying Xiao2, Hong Tan2.   

Abstract

Muc-1 is a member of the carbohydrate-binding protein family that contributes to neoplastic transformation, tumor survival, angiogenesis, and metastasis. The aim of this study is to investigate the role of muc-1 in human oral squamous cell carcinoma progression. In this study, we tested our hypothesis that muc-1 regulate oral squamous cell carcinoma cells (SCC-9) malignant biological behaviors, and silencing muc-1 reduced SCC-9 cellular colony forming ability, migration and invasion. Moreover, silenced cells present defects in phosphatidylinositol 3-kinase (PI3K)-serine/threonine kinase (Akt) signaling, and reduced expression/activity of matrix metallopeptidase (MMP)-2/9. Furthermore, in muc-1 siRNA-transfected cells, we detected a decrease in signal transducer and activator of transcription 3 (STAT3) phosphorylation and nuclear translocation. In vivo, muc-1 siRNA cells inoculated subcutaneously in nude mice demonstrated decreased tumor growth and PI3K-Akt signaling inhibition. These results indicate that muc-1 is a key factor in SCC-9 tumor migration, invasion, and suggesting that muc-1 can be a novel therapeutic target in oral squamous cell carcinoma.

Entities:  

Keywords:  Muc-1; Oral squamous cell carcinoma; RNA interference; tumor invasion

Mesh:

Substances:

Year:  2015        PMID: 26617744      PMCID: PMC4637559     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  15 in total

1.  MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells.

Authors:  Hasan Rajabi; Rehan Ahmad; Caining Jin; Michio Kosugi; Maroof Alam; Maya Datt Joshi; Donald Kufe
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

2.  4F2hc-silencing impairs tumorigenicity of HeLa cells via modulation of galectin-3 and β-catenin signaling, and MMP-2 expression.

Authors:  Angélica Santiago-Gómez; Juan I Barrasa; Nieves Olmo; Emilio Lecona; Hans Burghardt; Manuel Palacín; Ma Antonia Lizarbe; Javier Turnay
Journal:  Biochim Biophys Acta       Date:  2013-05-04

3.  Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin.

Authors:  Tsutomu Kobayashi; Tatsuo Shimura; Toshiki Yajima; Norio Kubo; Kenichiro Araki; Soichi Tsutsumi; Hideki Suzuki; Hiroyuki Kuwano; Avraham Raz
Journal:  Int J Cancer       Date:  2011-03-29       Impact factor: 7.396

4.  Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene.

Authors:  Xiaolong Wei; Hai Xu; Donald Kufe
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

5.  MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop.

Authors:  Rehan Ahmad; Hasan Rajabi; Michio Kosugi; Maya Datt Joshi; Maroof Alam; Baldev Vasir; Takeshi Kawano; Surender Kharbanda; Donald Kufe
Journal:  Sci Signal       Date:  2011-02-15       Impact factor: 8.192

6.  Immunobiology of human mucin 1 in a preclinical ovarian tumor model.

Authors:  R A Budiu; E Elishaev; J Brozick; M Lee; R P Edwards; P Kalinski; A M Vlad
Journal:  Oncogene       Date:  2012-09-10       Impact factor: 9.867

7.  A potent, imaging adenoviral vector driven by the cancer-selective mucin-1 promoter that targets breast cancer metastasis.

Authors:  Steven T Huyn; Jeremy B Burton; Makoto Sato; Michael Carey; Sanjiv S Gambhir; Lily Wu
Journal:  Clin Cancer Res       Date:  2009-04-14       Impact factor: 12.531

8.  MUC1 selectively targets human pancreatic cancer in orthotopic nude mouse models.

Authors:  Jeong Youp Park; Yukihiko Hiroshima; Jin Young Lee; Ali A Maawy; Robert M Hoffman; Michael Bouvet
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

9.  Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer.

Authors:  Jian Li; Yi-Ming Hu; Yong-Jie Du; Li-Rong Zhu; Hai Qian; Yan Wu; Wei-Lin Shi
Journal:  BMC Cancer       Date:  2014-11-19       Impact factor: 4.430

10.  Scoparone exerts anti-tumor activity against DU145 prostate cancer cells via inhibition of STAT3 activity.

Authors:  Jeong-Kook Kim; Joon-Young Kim; Han-Jong Kim; Keun-Gyu Park; Robert A Harris; Won-Jea Cho; Jae-Tae Lee; In-Kyu Lee
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

View more
  12 in total

1.  TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer.

Authors:  Sabine Heublein; Klaus Friese; Bernd Kost; Frederik Marmé; Christina Kuhn; Sven Mahner; Christian Dannecker; Doris Mayr; Udo Jeschke; Aurelia Vattai
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-30       Impact factor: 4.553

2.  Molecular biology of oral cavity squamous cell carcinoma.

Authors:  Phillip J Hsu; Kenneth Yan; Hailing Shi; Evgeny Izumchenko; Nishant Agrawal
Journal:  Oral Oncol       Date:  2020-01-07       Impact factor: 5.337

3.  Anticancer effect of curcumin inhibits cell growth through miR-21/PTEN/Akt pathway in breast cancer cell.

Authors:  Xinzheng Wang; Yakai Hang; Jinbiao Liu; Yongqiang Hou; Ning Wang; Mingjun Wang
Journal:  Oncol Lett       Date:  2017-04-20       Impact factor: 2.967

4.  Biomarker MicroRNAs for Diagnosis of Oral Squamous Cell Carcinoma Identified Based on Gene Expression Data and MicroRNA-mRNA Network Analysis.

Authors:  Hui Zhang; Tangxin Li; Linqing Zheng; Xiangya Huang
Journal:  Comput Math Methods Med       Date:  2017-09-17       Impact factor: 2.238

5.  MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells.

Authors:  Ai-Min Zhang; Xiao-Hui Chi; Zu-Qiang Bo; Xiao-Fang Huang; Jin Zhang
Journal:  Biosci Rep       Date:  2019-09-16       Impact factor: 3.840

6.  Syringic acid induces apoptosis in human oral squamous carcinoma cells through mitochondrial pathway.

Authors:  Bhaskhar Abijeth; Devaraj Ezhilarasan
Journal:  J Oral Maxillofac Pathol       Date:  2020-05-08

7.  MUC1 as a target for CAR-T therapy in head and neck squamous cell carinoma.

Authors:  Zi Mei; Kai Zhang; Alfred King-Yin Lam; Junwen Huang; Feng Qiu; Bin Qiao; Yi Zhang
Journal:  Cancer Med       Date:  2019-12-04       Impact factor: 4.452

8.  Silibinin Triggers the Mitochondrial Pathway of Apoptosis in Human Oral Squamous Carcinoma Cells.

Authors:  Radhika Murali Iyangar; Ezhilarasan Devaraj
Journal:  Asian Pac J Cancer Prev       Date:  2020-07-01

9.  Salivary proteome profiling of oral squamous cell carcinoma in a Hungarian population.

Authors:  Éva Csősz; Bernadett Márkus; Zsuzsanna Darula; Katalin F Medzihradszky; Judit Nemes; Emese Szabó; József Tőzsér; Csongor Kiss; Ildikó Márton
Journal:  FEBS Open Bio       Date:  2018-02-19       Impact factor: 2.693

Review 10.  Reactive Oxygen Species, Superoxide Dimutases, and PTEN-p53-AKT-MDM2 Signaling Loop Network in Mesenchymal Stem/Stromal Cells Regulation.

Authors:  Satoru Matsuda; Yukie Nakagawa; Yasuko Kitagishi; Atsuko Nakanishi; Toshiyuki Murai
Journal:  Cells       Date:  2018-05-01       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.